Success Stories: A Dominican Republic Scientist Successfully Secures both NIW and EB1A Approvals with Our Assistance and Premium Processing Support.

 

Client’s Testimonial:

“This is amazing news! Thank you for all the help!”


On January 30th, 2024 and August 19th, 2024, we received another EB-2 NIW (National Interest Waiver) and EB-1A (Alien of Extraordinary Ability) Approval for a Scientist in the Field of Biomedical Engineering (Approval Notice).


General Field: Biomedical Engineering

Position at the Time of Case Filing: Scientist

Country of Origin: Dominican Republic

State of Residence at the Time of Filing: Massachusetts

Approval Notice Date: January 30th, 2024 (NIW) and August 19th, 2024 (EB1A)

Processing Time: 8 days (NIW) (Premium Processing Requested) and 7 days (EB1A) (Premium Processing Requested)


Case Summary:

We had the honor of assisting a distinguished scientist with a Ph.D. degree in biomedical engineering in obtaining both her NIW and EB1A case approvals. Our team was deeply impressed by the significance and scope of this individual’s research. After conducting a preliminary review of her qualifications, our team agreed to process this case and develop a tailored petition package, which included the following key details:

  • Our client has published the results of her work in 14 peer-reviewed journal articles (10 of them first- or co-first-authored). Moreover, her papers have been published in some of the most discerning, high-impact journals in her field.
  • Due to its great applicability in the field of biomedical engineering, the scientist’s research has been cited 205 times, according to Google Scholar.
  • She also has conducted at least 16 reviews for top-ranked journals.
  • Her exceptional expertise in the field is further demonstrated by her considerable contributions to groundbreaking research funded by prestigious organizations such as te the National Science Foundation (NSF), the National Institutes of Health (NIH), the Defense Threat Reduction Agency (DTRA), and Revvity.
  • Last but not least, she received 6 recommendation letters from her peer scholars, proving recognition and respect for her research within the academia as one of the recommenders stated:

“I consider that [client’s] research is particularly of high interest within the scientific and technological landscape of the United States of America, as it aligns with national priorities in technological innovation and healthcare advancement…[Client’s] tools have an enormous potential to enhance diagnostic capabilities, improve healthcare delivery, and support biotechnological advancements, thereby strengthening the nation’s competitiveness at global scale, while addressing critical healthcare needs domestically.”

Thanks to the strategic approach and exhaustive focus on detail, we were able to secure both NIW and EB1A approvals for our client, ensuring that her outstanding work will continue to shape the future of biomedical engineering. We are grateful for the opportunity to support such a talented individual and wish her continued success in their future endeavors.